| OCTOBER, 2013 Gene-Related Patents Issued - Full patent: http://patft.uspto.gov/netahtml/PTO/srchnum.htm | ||||
| CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | ||||
| Pat No | Title | Assignee | Date Issued | Country |
| 8,546,143 | Compositions and methods for inhibiting expression of a target gene | Alnylam Pharmaceuticals, Inc. | 1-Oct-13 | United States |
| 8,557,584 | Preparing a homogenous population of stem cells committed to differentiated to a specific cell type | Ao-Forschungsinstitut Davos | 15-Oct-13 | Switzerland |
| 8,557,525 | Composite metastasis score with weighted coefficients for predicting breast cancer metastasis, and uses thereof | Celera Corporation | 15-Oct-13 | United States |
| 8,569,066 | Genetically engineered recombinant Escherichia coli producing L-tryptophan having originally L-phenylalanine productivity, and method for producing L-tryptophan using the microorganism | CJ Cheiljedang Corporation | 29-Oct-13 | Korea |
| 8,557,547 | Phosphotriesterase from agrobacterium radiobacter P230 | Commonwealth Scientific and Industrial Research Organisation | 15-Oct-13 | Australia |
| 8,546,120 | Perhydrolase variant providing improved specific activity | E. I. du Pont de Nemours and Company | 1-Oct-13 | United States |
| 8,557,556 | Perhydrolase variant providing improved specific activity | E. I. du Pont de Nemours and Company | 15-Oct-13 | United States |
| 8,546,119 | Perhydrolase variant providing improved specific activity | E. I. du Pont de Nemours and Company | 1-Oct-13 | United States |
| 8,569,065 | Compositions and methods for the delivery of biologically active RNAs | EGEN, Inc. | 29-Oct-13 | United States |
| 8,568,985 | Breast endothelial cell expression patterns | Genzyme Corporation | 29-Oct-13 | United States |
| 8,569,054 | Mammalian cell lines for increasing longevity and protein yield from a cell culture | Immunomedics, Inc. | 29-Oct-13 | United States |
| 8,563,270 | Calcium-binding photoprotein, gene encoding the same, and use thereof | JNC Corporation | 22-Oct-13 | Japan |
| 8,546,079 | Reporter gene construct, assay kit and detection method | Kabushiki Kaisha Toshiba | 1-Oct-13 | Japan |
| 8,569,038 | Transformant having an increased frequency of homologous recombination | Kikkoman Corporation | 29-Oct-13 | Japan |
| 8,551,772 | Detection of mutations in a gene associated with resistance to viral infection, OAS1 | Kineta Two, LLC | 8-Oct-13 | United States |
| 8,568,972 | Substances causing differentiation | Medicyte GmbH | 29-Oct-13 | Germany |
| 8,557,550 | Pyripyropene a biosynthetic gene | Meija Seika Pharma Co., Ltd. | 15-Oct-13 | Japan |
| 8,551,739 | Method for molecular cloning and polynucleotide synthesis using vaccinia DNA topoisomerase | Memorial Sloan-Kettering Cancer Center | 8-Oct-13 | United States |
| 8,569,051 | Expression vector for gene therapy | Mogam Biotechnology Research Institute | 29-Oct-13 | Korea |
| 8,568,980 | Nucleic acids, methods and kits for the diagnosis of DYT6 primary torsion dystonia | Mount Sinai School of Medicine | 29-Oct-13 | United States |
| 8,551,774 | Expression vectors containing a truncated epstein barr nuclear antigen 1 lacking the Gly-Gly-Ala domain for enhanced transient gene expression | National Research Council of Canada | 8-Oct-13 | Canada |
| 8,569,029 | DNase expression in recombinant host cells | Novozymes A/S | 29-Oct-13 | Denmark |
| 8,557,585 | Fusion polynucleotide for biosynthesis of beta-carotene using bicistronic gene expression and method for producing beta-carotene using the same | Republic of Korea, Rural Development Administration | 15-Oct-13 | Korea |
| 8,551,773 | Methods and compositions relating to improved lentiviral vectors and their applications | Research Development Foundation | 8-Oct-13 | United States |
| 8,563,314 | Methods and compositions for modulating PD1 | Sangamo BioSciences, Inc. | 22-Oct-13 | United States |
| 8,551,718 | Functional assay for 5-HT2A, histamine H1 or adrenergic alpha 1B receptors | Suven Life Science Limited | 8-Oct-13 | India |
| 8,551,700 | Diagnostic and prognostic tests | The Brigham and Women's Hospital, Inc. | 8-Oct-13 | United States |
| 8,557,532 | Diagnosis and treatment of drug-resistant Ewing'S sarcoma | The University of Utah Research Foundation | 15-Oct-13 | United States |
| 8,546,105 | Engineering intracellular sialylation pathways | The University of Wyoming | 1-Oct-13 | United States |
| 8,546,125 | Recombinant hosts and methods for manufacturing polyhydroxyalkanoate | Tianjin Greenbio Material Co., Ltd. | 1-Oct-13 | China P Rep. |
| 8,546,135 | In vivo genome-wide mutagenesis | University of Utah Research Foundation | 1-Oct-13 | United States |
| 8,551,775 | Subpopulations of spore-like cells and uses thereof | VBI Technologies, L.L.C. | 8-Oct-13 | United States |
| 8,551,734 | Selection and enrichment of proteins using in vitro compartmentalization | Zheng; Yu | 8-Oct-13 | United States |
| COMBINATORIAL CHEMISTRY TECHNOLOGY | ||||
| Pat No | Title | Assignee | Date Issued | Country |
| 8,557,745 | Markers and methods for assessing and treating Crohn's and related disorders | Janssen Biotech, Inc. | 15-Oct-13 | United States |
| 8,557,742 | Method of enhancing enzyme activity | Novozymes A/S | 15-Oct-13 | Denmark |
| DATA PROCESSING | ||||
| Pat No | Title | Assignee | Date Issued | Country |
| 8,548,747 | Optimizing genome-wide mutation analysis of chromosomes and genes | Children's Hospital Medical Center of Akron | 1-Oct-13 | United States |
| 8,566,039 | Method and system to characterize transcriptionally active regions and quantify sequence abundance for large scale sequencing data | Genomic Health, Inc. | 22-Oct-13 | United States |
| 8,560,334 | Method and arrangement for arranging an information service to determine nutrition and/or medication | Lahteenmaki; Pertti | 15-Oct-13 | Finland |
| 8,572,018 | Method, system and software arrangement for reconstructing formal descriptive models of processes from functional/modal data using suitable ontology | New York University | 29-Oct-13 | United States |
| DRUG | ||||
| Pat No | Title | Assignee | Date Issued | Country |
| 8,562,989 | Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer | Agensys, Inc. | 22-Oct-13 | United States |
| 8,562,985 | Antibodies to c-Met | Amgen Fremont Inc. | 22-Oct-13 | United States |
| 8,551,474 | Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase | Central Iowa Health System | 8-Oct-13 | United States |
| 8,552,069 | Method for treatment of obesity, dyslipidemia, fatty liver or insulin resistance syndrome comprising camphene as active ingredient | Industry-Academic Cooperation Foundation, Yonsei University | 8-Oct-13 | Korea |
| 8,557,246 | Fusion protein that directs vaccine antigens to antigen-presenting cells, and applications thereof | Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria | 15-Oct-13 | Spain |
| 8,557,779 | Cancer vaccine composition | International Institute of Cancer Immunology, Inc. | 15-Oct-13 | Japan |
| 8,568,745 | Water-soluble drug carrier and process for producing the same | Kyushu University, National University Corporation | 29-Oct-13 | Japan |
| 8,563,520 | Treatment of ocular disease with inhibitors of alpha2 macroglobulin protein | McGill University | 22-Oct-13 | Canada |
| 8,569,254 | Methods for modulating the expression and aggregation of CAG-expanded gene product in cells and methods for identifying agents useful for doing the same | National Yang Ming University | 29-Oct-13 | Taiwan |
| 8,551,970 | Genetic suppression and replacement | Optigen Patents Limited | 8-Oct-13 | Ireland |
| 8,557,875 | Gene transfer agent composition containing polyamidoamine dendron | Public University Corporation Osaka Prefecture University | 15-Oct-13 | Japan |
| 8,551,945 | Methods and compositions for treating neuropathies | Sangamo BioSciences, Inc. | 8-Oct-13 | United States |
| 8,568,708 | Tumor-specific delivery of therapeutic agents via liposomase | The John Hopkins University | 29-Oct-13 | United States |
| 8,551,481 | Anti-cancer vaccine composition comprising an anti-CD223 antibody and kit comprising an anti-cancer vaccine and an anti-CD223 antibody | The Johns Hopkins University | 8-Oct-13 | United States |
| 8,546,345 | Compositions and methods for siRNA inhibition of angiogenesis | The Trustees of the University of Pennsylvania | 1-Oct-13 | Canada |
| 8,563,511 | Treatment of pulmonary hypertension using an agent that inhibits a tissue factor pathway | University of Rochester | 22-Oct-13 | United States |
| MULTICELLULAR LIVING ORGANISMS | ||||
| Pat No | Title | Assignee | Date Issued | Country |
| 8,546,643 | Pig model for atherosclerosis | Aarhus Universitet | 1-Oct-13 | Denmark |
| 8,546,647 | Pathogen inducible plant thehalose-6-phophate phophatase gene promoters and regulatory elements | BASF Plant Science GmbH | 1-Oct-13 | Germany |
| 8,546,644 | Recombinant gene which enhances the ability of fish to tolerate low dissolved oxygen stress and the use thereof | Institute of Hydrobiology, Chinese Academy of Sciences (Wuhan, CN) | 1-Oct-13 | China P Rep. |
| 8,569,579 | BPMV-based viral constructs useful for VIGS and expression of heterologous proteins in legumes | Iowa State University Research Foundation, Inc. | 29-Oct-13 | United States |
| 8,552,256 | Gene capable of being expressed specifically in endosperm of plant, promoter for the gene, and use of the gene and the promoter | National Institute of Agrobiological Sciences | 8-Oct-13 | Japan |
| 8,558,055 | Genetically modified rat comprising a cytokine gene disruption and exhibiting a greater susceptibility to a cytokine-mediated autoimmune and/or inflammatory disease | Transposagen Biopharmaceuticals, Inc. | 15-Oct-13 | United States |
| 8,569,574 | Methods and compositions for improved fertilization and embryonic survival | Wisconsin Alumni Research Foundation | 29-Oct-13 | United States |
| NATURAL RESINS OR DERIVATIVES | ||||
| Pat No | Title | Assignee | Date Issued | Country |
| 8,569,454 | YS68 polypeptide involved in primitive hematopoiesis | Chugai Seiyaku Kabushiki Kaisha | 29-Oct-13 | Japan |
| 8,546,540 | Antibody targeting osteoclast-related protein Siglec-15 | Daiichi Sankyo Company, Limited | 1-Oct-13 | Japan |
| 8,563,684 | Tumor antigen protein SART-3 and tumor antigen peptides thereof | Green Peptide Co., Ltd. | 22-Oct-13 | Japan |
| ORGANIC COMPOUNDS | ||||
| Pat No | Title | Assignee | Date Issued | Country |
| 8,546,554 | Lipid formulated compositions and methods for inhibiting expression of Serum Amyloid A gene | Alnylam Pharmaceuticals, Inc. | 1-Oct-13 | United States |
| 8,569,469 | B.sub.12-dependent dehydratases with improved reaction kinetics | E I du Pont de Nemours and Company | 29-Oct-13 | United States |
| 8,569,473 | Pestivirus species | Intervet International B.V. | 29-Oct-13 | Netherlands |
| 8,569,474 | Double stranded constructs comprising one or more short strands hybridized to a longer strand | Isis Pharmaceuticals, Inc. | 29-Oct-13 | United States |
| 8,552,169 | Transcription factor-based biosensor | The Regents of the University of California | 8-Oct-13 | United States |
| 8,557,969 | Compositions and methods for regulating cardiac performance | The Regents of the University of Michigan | 15-Oct-13 | United States |
| 8,557,515 | Compositions and methods for cancer diagnosis and therapy | Thomas Jefferson University | 15-Oct-13 | United States |
| 8,551,971 | Composition for treatment of pancreatic cancer | Tokyo Women's Medical University | 8-Oct-13 | Japan |
| 8,552,170 | Expression vector for establishing highly productive cell and the highly productive cell | Toyo Boseki Kabushiki Kaisha | 8-Oct-13 | Japan |
| 8,552,171 | RNA sequence-specific mediators of RNA interference | University of Massachusetts | 8-Oct-13 | United States |
| 8,569,471 | Stem cell beacon | University of South Florida | 29-Oct-13 | United States |
| SURGERY | ||||
| Pat No | Title | Assignee | Date Issued | Country |
| 8,551,069 | Methods and apparatus for treating contrast nephropathy | Medtronic Adrian Luxembourg S.a.r.l. | 8-Oct-13 | Luxembourg |
Login
To traslate this page, click a flag!
Advertisements
Eden's Bounty Multi-SanTM
Colorless, odorless, biodegradable instant sanitizer is effective against both gram positive and gram-negative bacteria; kills in 30 seconds. Free of chlorine and quaternary ammonium compounds. EPA registered food contact surface sanitizer. Austin Davis Industries, Inc.
Colorless, odorless, biodegradable instant sanitizer is effective against both gram positive and gram-negative bacteria; kills in 30 seconds. Free of chlorine and quaternary ammonium compounds. EPA registered food contact surface sanitizer. Austin Davis Industries, Inc.
TERRA+ CLEAN Acid-Replacement Surface Cleaner
Safe, totally natural, 100% biodegradable, multi-functional cleaning product providing safety in the workplace for both humans and environmental surfaces - without compromising performance. Can be diluted up to 25:1. Austin Davis Industries, Inc.
Safe, totally natural, 100% biodegradable, multi-functional cleaning product providing safety in the workplace for both humans and environmental surfaces - without compromising performance. Can be diluted up to 25:1. Austin Davis Industries, Inc.
